story of the week
Matching-Adjusted Indirect Treatment Comparison of Ozanimod vs Teriflunomide for Relapsing MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Matching-Adjusted Indirect Treatment Comparison of Ozanimod Versus Teriflunomide for Relapsing Multiple Sclerosis
Mult Scler Relat Disord 2021 Jul 01;52(0)102972, S Cohan, T Tencer, S Arndorfer, X Zhu, M Zivkovic, J KumarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.